等待開盤 09-10 09:30:00 美东时间
0.000
0.00%
<p>NANO Nuclear Energy Inc. announced its participation in three upcoming investor events: H.C. Wainwright’s 27th Annual Global Investment Conference on September 8th, Benchmark’s Nuclear Innovation Summit on September 16th, and TD Cowen’s 10th Annual Nuclear Fuel Cycle and Next Generation Nuclear Roundtable on October 9th. The company, focused on advanced nuclear energy solutions, operates across five business lines including microreactor techno...
09-05 12:30
NANOBIOTIX, a late-clinical stage biotechnology company, announced that its management will participate in a fireside chat at the H.C. Wainwright 27th Annual Global Investment Conference on September 9, 2025. The event will take place in New York City at 9:00 am EDT / 3:00 pm CEST. CEO Laurent Levy and CFO Bart van Rhijn will present, with a live webcast available on the Company’s events page, followed by a replay. Nanobiotix, headquartered in Pa...
09-02 20:15
NANO Nuclear Energy Inc. has been awarded a $1.25 million Direct to Phase II contract by AFWERX to explore deploying its KRONOS MMR™ Energy System at Joint Base Anacostia-Bolling in Washington, D.C. The project aims to enhance energy resilience, reduce reliance on commercial grids, and provide secure, carbon-free power. The KRONOS MMR™ is a high-temperature gas-cooled microreactor designed for safety, autonomy, and multi-decade use.
09-02 11:30
NANO Nuclear Energy Inc. has signed a Memorandum of Understanding (MOU) with Dioxitek S.A., an Argentinian nuclear fuel company, to evaluate Argentina's uranium conversion infrastructure and explore collaboration in developing uranium enrichment capabilities. This initiative aims to support Argentina's nuclear supply chain and reduce reliance on foreign suppliers. The MOU aligns with NANO Nuclear's strategic expansion in Argentina and its goal to...
08-27 11:30
Nanobiotix, a late-stage clinical biotechnology company, announced its voting rights and share capital as of July 31, 2025. The company, listed on Euronext Paris and Nasdaq, reported 48,236,671 outstanding shares, with theoretical voting rights totaling 50,340,736 and exercisable voting rights at 50,318,618. Founded in 2003, Nanobiotix specializes in physics-based therapeutic approaches and holds over 25 patent families across oncology, bioavaila...
08-27 06:00
Nano Labs Ltd宣布,其董事长兼首席执行官Kong Jianping于8月通过公开市场交易增持了48万股A类普通股,这是继去年5月和9月之后的再次增持。Kong表示对公司的长期增长前景充满信心,并可能在未来考虑进一步增持。Nano Labs是一家领先的Web 3.0基础设施和产品解决方案提供商,专注于高吞吐量计算和高性能计算芯片,并在加密资产领域积极布局。
08-26 10:00
Nano Labs Ltd has entered into an At The Market Offering Agreement with Maxim Group LLC to sell up to $45 million worth of Class A Ordinary Shares. The funds will be used for BNB and crypto asset reserve strategies, product R&D, and general corporate purposes. The offering is detailed in the Prospectus Supplement filed with the SEC, available on its website or by contacting Maxim Group.
08-21 13:10
NANO Nuclear Energy Inc. has been selected to advance to the finals of the U.S. Army xTechSearch 9 competition. The company will showcase its deployable microreactor technology, which aims to provide resilient and
08-21 12:00
近期,BNB价格突破历史新高,多家美股公司将其纳入资产储备,ETF申请也助力其向机构储备资产转型。文章分析了BNB的机构化路径及散户参与机会:链上DeFi、RWA、Meme玩法,布局“BNB概念股”,参与币安活动,以及通缩机制带来的长期价值。BNB正在重估其价值,预计在机构与生态推动下开启新高度。
08-15 11:25
NANO Nuclear Energy Inc. (NASDAQ: NNE) announced its participation in several upcoming investor conferences, including the 14th Annual Needham Virtual Industrial Tech, Robotics, & Clean Tech Conference on August 18, 2025, the TD Securities Nuclear & Uranium Conference on September 2, 2025, in London, and Barclays’ 39th Annual Energy-Power Conference on September 2, 2025, in New York. The company will not present formally at these events but plans...
08-13 12:30